Autopsy report · NCT00451841
Exhaled Breath Condensate pH in Patients With Cough Caused by Gastroesophageal Reflux
Cause of deathSlow enrollment, also regulatory or ethics
“IRB approval not renewed/approval lapsed. Prior status: insufficient enrollment; study suspended pending analysis”
Life of this trial
- Ran for about 6 years 3 months before it stopped.
- 30 participants planned (an estimate, not an actual count).
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Sponsor
- University of Massachusetts, Worcester
- Sponsor type
- University, hospital or other
- Conditions
- Cough; Gastroesophageal Reflux
- Interventions
- RTube Exhaled Breath Condensate Collection System
- Participants
- 30 (planned, not actual)
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Simvastatin Nasal Rinses for the Treatment of COVID-19 Mediated Dysomsia
“Study halted prematurely; IRB approval not obtained” - Adherence to Otezla
“Terminated IRB approval 6/26/2024, study was never initiated or activated” - Psychiatric Outcomes of Unruptured Intracranial Aneurysms (POUIA)
“IRB approval has lapsed. Study has submitted continuing review report for re-certification. Awaiting IRB re-approval.” - A Surgical Approach to the Management of Type II Diabetes Mellitus in Patients With a BMI Between 25-35 kg/m2
“IRB temporarily halted enrollment” - Low-Level Transcutaneous Vagus Stimulation in ST Segment Elevation Myocardial Infarction: TREAT MI Study
“Study never initiated; withdrawn prior to receiving IRB approval”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.